Respiratory

A new study supports the clinical utility of human nasal epithelial cultures as predictive biomarkers for cystic fibrosis CFTR modulator therapy.

Blood eosinophil count and fractional exhaled nitric oxide significantly enhance prognostic assessment of asthma attack risk.

A single dose of the RSVPreF3 OA vaccine offers strong protection against RSV-related lower respiratory tract disease in older adults across three seasons.

Explore how vaping during pregnancy affects maternal health and birth outcomes.

A new 96-week study confirms the long-term safety and sustained efficacy of elexacaftor/tezacaftor/ivacaftor in children with cystic fibrosis aged 6–11 years.

Inpatient pulmonary rehabilitation significantly enhances functional independence in patients with chronic lung disease and extends survival.

A study analysing trends in mortality from occupational chronic respiratory diseases caused by industrial pollutants highlights both progress and ongoing challenges.

Early exposure to ambient ozone in the first 2 years of life is associated with an increased risk of asthma and wheeze in early childhood.